79.49MMarket Cap-1099P/E (TTM)
4.1700High3.7500Low142.73KVolume3.7900Open3.8200Pre Close562.18KTurnover0.68%Turnover RatioLossP/E (Static)21.14MShares7.420052wk High11.53P/B78.89MFloat Cap1.010052wk Low--Dividend TTM20.98MShs Float309.6000Historical High--Div YieldTTM11.00%Amplitude1.0100Historical Low3.9380Avg Price1Lot Size
Aileron Therapeutics Stock Forum
NEWS
Aileron Therapeutics Announces Pricing of Underwritten Registered Direct Offering Priced At-The-Market Under Nasdaq Rules of up to Approximately $40 Million
NEWS
Aileron Therapeutics Announces Positive Data from Cohort 1 of the Phase 1b Clinical Trial of LTI-03 in Idiopathic Pulmonary Fibrosis (IPF)
Aileron Therapeutics, Inc. announced positive data from Cohort 1 of the Phase 1b clinical trial of LTI-03 in IPF. Low-dose LTI-03 showed reductions in profibrotic proteins, increased expression of biomarkers, and was well-tolerated. Positive trends were observed in seven out of eight biomarkers. Data from Cohort 2 is expec...
Shhh! Hehehe!
Make a note!
Wonder what's the news?
Nov 17 low priced watchlists
Expected dips below 1?
Suspended news
Quite a good dips but watch first
No comment yet